A Phase I/IIa Trial to Test Safety and Feasibility of iPSC-Derived RPE Patch in Macular Degeneration Patients

Time: 10:45 am
day: Day Two

Details:

  • Autologous iPSC manufacturing process
  • QC for clinical-grade iPSC
  • Efficient RPE differentiation process for improving manufacturing robustness

Speakers: